< Back to latest news & events

HGF Presents

Patenting Polymorphs at the EPO

September 2025

Video overview:

Novelty and Inventive Step

  • Prior art must necessarily lead to the claimed polymorph to be novelty destroying
  • Watch out for inherent disclosures in prior art—methods may implicitly produce polymorphs even if structural data isn’t provided.
  • Provide experimental evidence if needed to show prior art does not produce the claimed polymorph.
  • Emphasize any advantages or unexpected properties of the polymorph, ideally supported by data, to support an inventive step, in the application.
  • Highlight advantages of the polymorph versus other forms.

Clarity

  • Provide a clear, precise definition of the polymorph.
  • Clearly define the crystalline form using appropriate physicochemical parameters and measurement conditions.

Sufficiency

  • Clearly describe how to prepare the polymorph. If preparation requires seeding crystals, disclose how to prepare the seed in the application.

Latest updates

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article

HGF Highly Ranked in Legal 500 2026

The Legal 500 UK 2026 rankings have been released and HGF has once again been ranked across several regions and practice areas. HGF continue to be ranked in the Top-Tier …

Read article

12 HGF Attorneys Recognised as Managing IP Rising Stars 2025

We are very proud to announce that 12 of our attorneys have been recognised as Rising Stars in the latest Managing IP Rankings! This accolade celebrates the next generation of …

Read article

IP Ingredients: The companies making – and patenting - alt coffee

How do you like your coffee? Frothy or flat? Milky or black? Oat-milk or soy?  How about coffee which isn’t derived from coffee beans? Coffee is the second most traded …

Read article
Event - 29th September 2025

HGF are Bronze Sponsors of the LES Pan-European Conference 2025

We are proud to be a bronze sponsor of the LES Pan-European Conference 2025, taking place on the 29-30th September 2025 at The Hague Marriott Hotel, The Netherlands. This year’s …

Event details